Patents by Inventor Batya Cohen

Batya Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reporter genes for magnetic resonance imaging and methods of use thereof
    Patent number: 9387264
    Abstract: The invention provides a fusion ferritin protein wherein a ferritin heavy chain polypeptide is fused to a peptide, wherein the peptide is fused to the C-terminal end of the ferritin heavy chain; and the peptide includes at least a portion of a Mms6 protein sequence and at least one heterologous amino acid at its N-terminal end. The invention further provides methods of use of the ferritin fusion protein for Magnetic Resonance Imaging.
    Type: Grant
    Filed: April 4, 2013
    Date of Patent: July 12, 2016
    Assignees: YEDA RESEARCH AND DEVELOPMENT CO. LTD., THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV
    Inventors: Michal Neeman, Raz Zarivach, Marina Radoul, Batya Cohen, Moriel Vandsburger, Limor Lewin
  • REPORTER GENES FOR MAGENTIC RESONANCE IMAGING AND METHODS OF USE THEREOF
    Publication number: 20130280173
    Abstract: The invention provides a fusion ferritin protein wherein a ferritin heavy chain polypeptide is fused to a peptide, wherein the peptide is fused to the C-terminal end of the ferritin heavy chain; and the peptide includes at least a portion of a Mms6 protein sequence and at least one heterologous amino acid at its N-terminal end. The invention further provides methods of use of the ferritin fusion protein for Magnetic Resonance Imaging.
    Type: Application
    Filed: April 4, 2013
    Publication date: October 24, 2013
    Inventors: Michal NEEMAN, Raz Zarivach, Marina Radoul, Batya Cohen, Moriel Vandsburger, Limor Lewin
  • COMPOSITIONS AND METHODS FOR MODULATING VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) EXPRESSION
    Publication number: 20100291036
    Abstract: The present invention relates to compounds and methods for inhibiting the expression of vascular endothelial growth factor-C (VEGF-C) in a target cell. Particularly, the present invention relates to antisense polynucleotides complementary to a lens epithelium-derived growth factor (LEDGF/p75) mRNA and uses thereof for inhibiting tumor progression and tumor metastasis. The present invention further relates to uses of LEDGF/p75 polypeptide or a nucleic acid encoding same for treating endothelial cell related conditions, particularly inflammation and edema.
    Type: Application
    Filed: January 25, 2009
    Publication date: November 18, 2010
    Applicant: YEDA RESEARCH AND DEVELOPMENT CO.LTD, at The Weizmann Institute of Science
    Inventors: Michal Neeman, Batya Cohen, Stav Sapoznik, Shifra Ben-Dor, Gila Meir
  • Leptin assay
    Patent number: 7247427
    Abstract: The invention provides a method for determining the presence of leptin in a sample.
    Type: Grant
    Filed: October 5, 2000
    Date of Patent: July 24, 2007
    Assignee: Yeda Research and Development Co., Ltd.
    Inventors: Menachem Rubinstein, Batya Cohen
  • Leptin as an inhibitor of tumor cell proliferation
    Patent number: 7109159
    Abstract: The use of leptin and leptin-related molecules in oncology is disclosed.
    Type: Grant
    Filed: April 26, 1998
    Date of Patent: September 19, 2006
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Dalit Barkan, Batya Cohen, Menachem Rubinstein
  • Methods, pharmaceutical compositions and articles of manufacture for treating disorders associated with abnormal cell proliferation and apoptosis
    Publication number: 20030158251
    Abstract: A method of treating disorders associated with abnormal cell proliferation in a subject in need thereof is provided. The method is effected by administering to the subject a therapeutically effective amount of an agent capable of inhibiting NQO1 activity.
    Type: Application
    Filed: January 29, 2002
    Publication date: August 21, 2003
    Inventors: Gad Asher, Joseph Lotem, Batya Cohen, Leo Sachs, Yosef Shaul
  • Interferon-&agr;/&bgr; binding protein, its preparation and use
    Patent number: 6458932
    Abstract: Interferon &agr;/&bgr; binding proteins are provided, which are capable of modulating the activity of interferon-&agr; subtypes as well as interferon-&bgr;. Cloning of DNA molecules encoding these proteins, expression in host cells and antibodies against the proteins are also provided.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 1, 2002
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Daniela Novick, Batya Cohen, Menachem Rubinstein
  • Nucleic acid encoding interferon-.alpha./.beta. binding protein
    Patent number: 5821078
    Abstract: Interferon .alpha./.beta. binding proteins are provided, which are capable of modulating the activity of interferon-.alpha. subtypes as well as interferon-.beta.. Cloning of DNA molecules encoding these proteins, expression in host cells and antibodies against the proteins are also provided.
    Type: Grant
    Filed: February 7, 1995
    Date of Patent: October 13, 1998
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Daniela Novick, Batya Cohen, Menachem Rubinstein